We previously reported that, in a mouse model of mammary cancer, a-mangostin alone exhibits anti-metastatic properties. To enhance this anti-metastatic effect, we examined the efficacy of synthetic a-mangostin dilaurate (MGD), prepared by adding lauric acid to a-mangostin, in the same experimental system wherein mice bearing mammary tumors are exposed to dietary MGD at 0, 2000 and 4000 ppm. Lauric acid has a high propensity for lymphatic absorption, which is the most common pathway of initial dissemination of many solid malignancies. Both mammary tumor volumes and wide-spectrum organ metastasis were markedly reduced at 2000 and 4000 ppm: furthermore, survival in the 4000-ppm group was significantly greater than in control mice. Apoptosis in mammary carcinomas was also significantly increased in the 4000-ppm group, whereas blood microvessel density and lymphatic vessel invasion were markedly reduced. In real-time PCR analyses of tumor samples, increased p21 and decreased Pcna expression were observed with 4000 ppm but values were not statistically significant when compared to expression in control tumors. However, exposure to 4000 ppm significantly decreased expression of phospho-Akt (Ser473/Thr308) as compared to the control, indicating a role in the anti-tumorigenic effects of MGD. These findings suggest that MGD may be useful for adjuvant therapy and chemoprevention and that conjugated medium-chain fatty acids may enhance the efficacy of certain chemotherapeutic agents. 
mangosteen extracts (eg, inhibition of aberrant crypt foci in rat colon carcinogenesis), 7 and of tumor growth in xenograft animal models of human colorectal 8 and prostate cancers. 9 Fatty acids are bioactive molecules classified by their carbon atom chain length as short-chain (<8 carbon atoms), medium-chain (8-14 carbon atoms) and long-chain (>16 carbon atoms). 10 While 3-carbon fatty acid chains have been shown to induce apoptosis in several neoplastic cell lines, [11] [12] [13] lauric acid, a large component of medium-chain triglycerides, has been reported to inhibit prostate hyperplastic lesions in rats in vivo: 14 in addition, lauric acid has a higher propensity for lymphatic absorption compared to the long-chain octanoic acid, 15, 16 which is significant because the most common pathway of initial dissemination of many solid malignancies is known to be via the lymphatics. 17 We wanted, therefore, to determine whether the anti-metastatic properties demonstrated by a-mangostin could be enhanced by the addition of mediumchain lauric acid (C12; dodecanoic acid) to form a-mangostin dilaurate (MGD) in our previously used mouse model of mammary cancer.
| MATERIALS AND METHODS

| a-mangostin dilaurate preparation
We extracted a-mangostin ( Figure 1A ) from dried mangosteen peri- 
| Cell line and animals
Mammary tumors arising from BJMC3879 cell implantation have mutant p53 and an especially high metastatic predilection for the lymph nodes and lungs, [18] [19] [20] a trait retained through culture. To monitor the in vivo progression and dissemination, we performed a stable transfection of the BJMC3879 parent cell line with luc2, an improved firefly luciferase gene, to generate the BJMC3879Luc2 mammary carcinoma cell line. 21 BJMC3879Luc2 cells used in this study were maintained in DMEM with 10% FBS and penicillin-streptomycin and grown in an incubator under 5% CO 2 at 37°C.
Forty 5-week-old female BALB/c mice were purchased from Japan SLC, Hamamatsu, Japan. in PBS prior to bioluminescence imaging using a Photon Imager (Biospace Lab, Paris, France).
| Preparation for histopathological analyses
At necropsy, we harvested tumors and lymph nodes from all mice from the axillary and femoral regions, along with any other lymph nodes that appeared abnormal, and fixed the tissues in 10% phosphate buffered formalin (PBF) solution. Lungs, kidneys, adrenals, ovaries, and other tissues/organs that appeared abnormal were also routinely excised and immersed in PBF for formalin-fixed paraffin-embedded (FFPE) tissues.
All FFPE tissues were cut at sequential 4-lm sections for histopathological analysis using H&E and immunohistochemical staining. BrdU labeling indices were expressed as numbers per cm 2 .
| Densities of blood microvessels and lymphatic vessel invasion in tumors
CD31 is a marker for the endothelium of blood vessels, whereas podoplanin is a marker for lymphatic endothelium. Tumor sections were exposed to antibodies for each marker and the numbers of CD31-positive blood microvessels were counted as previously described; 23 briefly, the slides were scanned at low-power (9100) 
| Real-time PCR analysis in tumors
To avoid the inclusion of necrotic and mesenchymal tissues in realtime PCR analysis of Pcna and p21, we specifically microdissected only viable mammary carcinoma tissues from FFPE tumors using a laser microdissector (LMD7000; Leica Microsystems, Wetzlar, Germany).
Total RNA was then extracted from microdissected samples using the RNeasy FFPE Kit (Qiagen, GmbH, Hilden, Germany) and cDNA synthesized using a Primer Script RT Reagent Kit with gDNA Eraser (Takara Bio, Otsu, Shiga, Japan). We subsequently amplified resulting cDNA using a Thermal Cycler Dice Real-time System (Takara Bio) and SYBR Premix Ex TaqII (Takara Bio). The Gapdh gene was used as an internal control. Amplification cycles were as follows: an initial step at 95°C for 30 seconds, followed by 45 cycles of 5 seconds at 95°C, 10 seconds at 58°C, and 20 seconds at 72°C. The primer sequences were designed to generate PCR products smaller than 100 bp in FFPE samples and are shown in Table 1 . Relative gene expression levels were normalized to Gapdh (DCt) and expressed as fold changes calculated using the 2 ÀDDCt method, as described previously. 24 
| Statistical analysis
Kaplan-Meier survival curves were plotted according to the number of deaths in each group, and the differences in survival rates determined using the log-rank test. The Kruskal-Wallis H-test was conducted; when the data were significant, Dunn's test (a non-parametric multiple comparison) was also used. The Mann-Whitney U-test (an unpaired group and non-parametric analysis) was used to compare the data generated by real-time PCR analysis in control and 4000 ppm-treated groups. Data are expressed as mean AE SD and differences are considered statistically significant when P < .05. there was a decrease in metastatic expansion in MGD-treated mice compared to that in control animals ( Figure 2D ).
T A B L E 1 Mouse primer sequences for real-time PCR for formalin-fixed paraffin-embedded samples
Forward AACATCTCAGGGCCGAAAAC 60
Reverse CGCTTGGAGTGATAGAAATCTGTC
Pcna
Forward ACTTGGAATCCCAGAACAGG 55
Reverse TTCACCCGACGGCATCT
Gapdh Forward GGAGTAAGAAACCCTGGACCAC 66
Reverse AGTTGGGATAGGGCCTCTCTTG F I G U R E 2 (A) Survival rates in the 4000-ppm group were significantly higher than in the control group, whereas body weights (B) of mice given a-mangostin dilaurate (MGD) were comparable to those in the control group. C, Tumor volumes were smaller with continuous exposure to both 2000 and 4000 ppm. D, Bioluminescence imaging in 5 representative mice from each group. Bioluminescence imaging demonstrated decreases in the extension of metastasis in MGD-treated groups compared to the control group. *P < .05, **P < .01
| Metastasis of mammary carcinomas
Primary mammary carcinomas induced by BJMC3879Luc2 inoculation proved to be mutant p53 protein-positive adenocarcinomas showing less glandular formation ( Figure 3A ) 25 ( Figure 3B ). Representative lymph node metastases are shown in Figure 3C ,D. The number of metastasis-positive lymph nodes per mouse was significantly decreased in both the 2000-ppm and 4000-ppm groups compared to that in the control group ( Figure 3G ). Metastatic lung foci were larger and more frequent in control mice ( Figure 3E ) compared to those in MGD-treated mice ( Figure 3F ), and the number of metastatic foci ≥250 lm was also significantly decreased in both MGD-treated groups ( Figure 3H ). Metastatic foci were also observed in the kidneys, adrenals, ovaries and mediastinum ( Figure 4A-D) . 
| Apoptosis and cell proliferation in mammary carcinomas
Representative tumor sections showing TUNEL-positive apoptotic cells are presented in Figure 5A ,B. Results of quantitative analyses for apoptosis in mammary tumors are shown in Figure 5E . The number of TUNEL-positive cells was significantly increased in tumors exposed to 4000-ppm MGD compared to the tumors from control mice ( Figure 5E ). In addition, the expression of active caspase-3 was much higher in mammary tumors treated with MGD (inset, Fig- ure 5B) than in the control tumors (inset, Figure 5A ), suggesting that MGD administration induced apoptotic cell death. Increased caspase-3 activity in vivo is notable because caspase-3 is the final executor of apoptosis and the most significant member of the apoptotic pathway.
Cell proliferation was examined in the mammary carcinomas of MGD-treated mice using BrdU immunohistochemistry, as shown in Figure 5C ,D. The BrdU labeling indices in tumors were decreased in both MGD-treated groups in a dose-dependent manner, but not to a statistically significant level ( Figure 5F ).
| Blood microvascular densities and lymphatic vessel invasion
Blood microvascular density determined by CD31 immunohistochemistry (arrows in Figure 6A ,B) was significantly decreased in the 4000-ppm group compared to that in the control group ( Figure 6E ).
Tumor cells found within the lumina of dilated podoplanin-positive lymphatic vessels of tumors in both the control ( Figure 6C ) and MGD-treated animals ( Figure 6D ) indicated the occurrence of lymphatic vessel invasion; however, the numbers of invaded lymphatic vessels decreased in mammary tumors from both MGD-treated groups ( Figure 6F ), but statistical significance was observed only at 
| Transcriptional levels of p21 and Pcna in mammary carcinomas
Samples from FFPE mammary carcinomas, microdissected from surrounding mesenchyma ( Figure 7A ) and necrosis, provided viable and pure tumor tissues for evaluating the expression of p21 and Pcna by real-time PCR. Compared to tissues from control mice, p21 showed a 25% increase in tissues from mice treated with 4000 ppm, whereas Pcna levels decreased by 23% ( Figure 7B ). However, these fluctuations were not statistically significant.
| Effects of Akt phosphorylation by
a-mangostin dilaurate and certain anti-angiogenesis effects. [3] [4] [5] [6] PCNA is essential for replication 27 and p21 has been shown to interact with PCNA and induce arrest at G1. 28, 29 Increased p21 and decreased Pcna mRNA levels were observed in the 4000-ppm tissues with real-time PCR analysis.
Because cancer is characterized by uncontrolled cell proliferation resulting from abnormal activity of various cell cycle proteins, cell cycle regulators are considered attractive targets in cancer therapy. 30 Fatty acids are bioactive molecules classified as short-chain, medium-chain and long-chain in terms of the number of carbon atoms present in the chain. On their own, fatty acids are known to induce apoptosis in cancer cell lines, 12, 13 and the number of carbon atoms (Cn) in their chains are believed to be a critical factor influencing their cytotoxicity. 11 Compared to short-chain fatty acids like butyrate, the medium-chain lauric acid induces preferential apoptosis and is associated with suppression of cell cycle processes as well as increased generation of glutathione-independent reactive oxygen species. 31 Oral administration of either lauric acid (C12) or myristic acid (C14) significantly inhibits in vivo development of testosteroneinduced prostatic hyperplasia in rats 14 and evidence for the anti-proliferative effects, particularly of lauric acid, is accumulating. Although there is some overlap in the cumulative absorption of medium-chain and long-chain fatty acids via the portal vein and lymphatics, there are significant differences in their routes and rates of absorption.
For example, approximately 4 times as much as lauric acid is absorbed via the lymphatics vs the portal vein, whereas the opposite is true for long-chain octanoic acid. 15, 16 It should be noted that the most common pathway of initial dissemination of various solid malignancies is the lymphatic system. 17 Lauric acid is further reported to possess anti-viral 32 and anti-bacterial 33 properties and can destroy lipid-coated viruses. Breast milk contains high concentrations of both lauric and myristic acids, 34 contributing to the myriad health benefits for breast-fed infants. Medium-chain fatty acids are also less efficiently stored in the body than other fatty acids and are highly prone immunohistochemistry; (C,D) podoplanin immunohistochemistry. Scale bars: 50 lm; *P < .05; **P < .01; numerals in parentheses indicate the number of animals examined to oxidative metabolism once ingested, implying that they are unlikely to contribute to obesity via direct storage in adipocytes, and may be useful in dietary regimens. 35 In this study, synthetic MGD significantly suppressed wide-spectrum organ metastasis, including that to the lymph nodes and lungs.
We were unable to include an a-mangostin-treated group in this study because of the high cost of purified a-mangostin and could not, therefore, directly compare the anti-tumor effects of a-mangostin and MGD. A previous study using a-mangostin at the same dietary concentration (4000 ppm) 36 revealed a 2-fold amplification of inhibitory effects by MGD on lung and lymph node metastasis compared with mice given a-mangostin alone (42% vs 23%).
Neovascularization through angiogenesis is a key process in the growth of solid tumors, both primary and metastatic; tumors do not grow beyond a few cubic millimeters unless a vascular network is established to feed further expansion. 37 This makes inhibition of angiogenesis and hematogenous metastases crucial targets of cancer therapies. 38 However, as previously stated, the lymphatic system is the most common pathway of initial spread of solid tumors 17 and, thus, constitutes another front for the treatment and inhibition of metastatic spread. In fact, lymph node metastasis is the most clinically influential prognostic factor in cases of breast cancer. 39 MGD significantly inhibited the multiplicity of lymph node metastasis in mice administered either dose in the current study, supported by a significant reduction in the frequency of lymphatic vessel invasion in the MGD-treated mice.
Akt phosphorylation contributes to cell proliferation, apoptotic cell death, cell cycle entry, angiogenesis and metastasis: all important aspects of the oncogenic process. 40 To be fully activated, Akt requires phosphorylation at 2 specific amino acid residues, Thr308 and Ser473. Several modes of Akt dysregulation have been identified in various types of cancer, including breast cancer, which ultimately affect such processes as cell growth, survival, proliferation, motility and/or invasion. 40 The present study demonstrated that MGD administration decreased expression of phospho-Akt (Ser473/ Thr308). The inhibition of tumor growth, angiogenesis and F I G U R E 7 A, Viable regions of mammary carcinomas were microdissected from formalin-fixed paraffin-embedded (FFPE) samples to exclude the mesenchymal and necrotic tissues (hematoxylin counterstain); p21 and Pcna levels in microdissected sections were then analyzed by real-time PCR. B, Box and whisker plot showing the relative expression levels for p21 and Pcna in FFPE tumor samples. An increase in the relative levels of p21 and a decrease in relative levels of Pcna were observed in tissues from the 4000-ppm group, but neither was statistically significant. The boxes represent the 25th to 75th percentiles, and horizontal lines within the box represent median values. The whiskers extend either to 10th and 90th percentiles, respectively. The number of mice examined was reduced to 4 in each group due to degraded RNA from FFPE samples causing poor amplification and/or aberrant dissociation temperatures of Gapdh metastasis in conjunction with increased apoptosis and alterations in cell-cycle molecules that we observed may be at least partially due to decreased Akt-phosphorylation. In addition, although the p53/Akt network is an important module that controls pathways to cell survival or death, 41 because the mammary carcinoma cells used in the present study contain mutant p53, Akt regulation observed in the present study was considered to be p53-independent. Akt inhibitors have shown significant promise preclinically and are now in clinical trials; 42 in fact, the PI3K/Akt pathway is now considered to be an important therapeutic target in cancer treatment.
Dietary administration of MGD strongly suppressed tumor growth and metastases to a wide spectrum of organs in BJMC3879Luc2-inoculated mice. Because these cells carry mutant p53, these inhibitory effects likely occur through a p53-independent mechanism involving suppression of Akt phospohorylation.
Approximately half of human cancers harbor p53 mutations 43 and, thus, MGD may be highly relevant to human cancer therapy. This study also indicates the benefit of conjugation with medium-chain fatty acids to enhance the effects of certain chemotherapeutic agents.
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The authors have no conflicts of interest to declare. showed a tendency for far less expansion of phospho-Akt-positive areas in a mouse receiving 4000-ppm compared to tissue from a control. As presented in a scatter plot diagram (G, red circle indicates mean), the percentage of areas demonstrating phospho-Akt expression was significantly decreased in the 4000-ppm MGD group compared to that in the control group. Scale bars: 50 lm; [G] **P < .01; numerals in parentheses indicate the number of animals examined
